Amelioration of obesity-induced white adipose tissue inflammation by Bacillus coagulans T4 in a high-fat diet-induced obese murine model.

[1]  L. D. den Hartigh,et al.  Modulation of Adipocyte Metabolism by Microbial Short-Chain Fatty Acids , 2021, Nutrients.

[2]  Y. Sanz,et al.  The gut microbiota as a versatile immunomodulator in obesity and associated metabolic disorders. , 2021, Best practice & research. Clinical endocrinology & metabolism.

[3]  T. Behl,et al.  Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium , 2021, Microorganisms.

[4]  Daping Fan,et al.  Impact of weight loss and partial weight regain on immune cell and inflammatory markers in adipose tissue in male mice. , 2020, Journal of applied physiology.

[5]  R. Urtasun,et al.  A Combination of Apple Vinegar Drink with Bacillus coagulans Ameliorates High Fat Diet-Induced Body Weight Gain, Insulin Resistance and Hepatic Steatosis , 2020, Nutrients.

[6]  M. Marzorati,et al.  Bacillus subtilis HU58 and Bacillus coagulans SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in an M-SHIME® Model , 2020, Microorganisms.

[7]  I. Casimiro,et al.  Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL/6J mice. , 2020, Journal of diabetes and its complications.

[8]  Yingping Xiao,et al.  Microbial Community and Short-Chain Fatty Acid Mapping in the Intestinal Tract of Quail , 2020, Animals : an open access journal from MDPI.

[9]  P. Pasalar,et al.  Resveratrol alleviates obesity-induced skeletal muscle inflammation via decreasing M1 macrophage polarization and increasing the regulatory T cell population , 2020, Scientific Reports.

[10]  Ning Wang,et al.  Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems , 2020, Frontiers in Microbiology.

[11]  B. Larijani,et al.  Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults , 2020, Journal of Diabetes & Metabolic Disorders.

[12]  S. Ghosh,et al.  Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development , 2020, Journal of the Endocrine Society.

[13]  Wei‐Jen Chen,et al.  Bacillus coagulans BC198 and Lactobacillus paracasei S38 in combination reduce body fat accumulation and modulate gut microbiota , 2020 .

[14]  E. Huarte,et al.  Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity , 2020, Nutrients.

[15]  J. Schilling,et al.  The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity , 2020, Frontiers in Immunology.

[16]  A. Masotti,et al.  The First Report of Differences in Gut Microbiota Composition between Obese and Normal Weight Iranian Subjects , 2019, Iranian biomedical journal.

[17]  H. Paik,et al.  Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier , 2019, Food Science and Biotechnology.

[18]  E. Blaak,et al.  The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity , 2019, Nutrients.

[19]  S. Parthasarathy,et al.  Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. , 2019, Advances in nutrition.

[20]  Y. Mu,et al.  Bacillus coagulans and its applications in medicine. , 2019, Beneficial microbes.

[21]  Young-Mo Kim,et al.  Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice , 2019, Cell.

[22]  H. Qin,et al.  Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. , 2019, Nutrition.

[23]  Chun-Ying Wu,et al.  The gut microbiome in obesity. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[24]  F. Tinahones,et al.  Metabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity. , 2019, American journal of physiology. Endocrinology and metabolism.

[25]  M. Covasa,et al.  Probiotics: How Effective Are They in the Fight against Obesity? , 2019, Nutrients.

[26]  W. Holzapfel,et al.  Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice , 2018, PloS one.

[27]  S. Hosseinzadeh,et al.  Effect of Probiotics Bacillus coagulans and Lactobacillus plantarum on Lipid Profile and Feces Bacteria of Rats Fed Cholesterol-Enriched Diet , 2018, Probiotics and Antimicrobial Proteins.

[28]  L. Russo,et al.  Properties and functions of adipose tissue macrophages in obesity , 2018, Immunology.

[29]  Fajun Yang,et al.  Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues , 2018, Nutrients.

[30]  E. Chambers,et al.  Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health , 2018, Current Nutrition Reports.

[31]  E. Blaak,et al.  Ectopic Fat Accumulation in Distinct Insulin Resistant Phenotypes; Targets for Personalized Nutritional Interventions , 2018, Front. Nutr..

[32]  G. Frühbeck,et al.  Adipokine dysregulation and adipose tissue inflammation in human obesity , 2018, European journal of clinical investigation.

[33]  Z. Erginkaya,et al.  Potential Use of Bacillus coagulans in the Food Industry , 2018, Foods.

[34]  Yanshu Li,et al.  High-Fat Diet Induces Dysbiosis of Gastric Microbiota Prior to Gut Microbiota in Association With Metabolic Disorders in Mice , 2018, Front. Microbiol..

[35]  R. Alfenas,et al.  Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity , 2018, International journal of food sciences and nutrition.

[36]  Min Zhang,et al.  Expression of a recombinant hybrid antimicrobial peptide magainin II-cecropin B in the mycelium of the medicinal fungus Cordyceps militaris and its validation in mice , 2018, Microbial Cell Factories.

[37]  Mitra S. Ganewatta,et al.  Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity , 2017, Scientific Reports.

[38]  L. Kaplan,et al.  The Human Microbiome and Obesity: Moving beyond Associations. , 2017, Cell host & microbe.

[39]  T. Dinan,et al.  The microbiota-gut-brain axis in obesity. , 2017, The lancet. Gastroenterology & hepatology.

[40]  Harsh Panwar,et al.  Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives , 2017, Front. Microbiol..

[41]  T. Wadden,et al.  Mechanisms, Pathophysiology, and Management of Obesity , 2017, The New England journal of medicine.

[42]  S. Duncan,et al.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics , 2017, The ISME Journal.

[43]  K. Qi,et al.  Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota , 2016, Scientific Reports.

[44]  Y. V. Lisnyak,et al.  Immunotropic aspect of the Bacillus coagulans probiotic action , 2016, bioRxiv.

[45]  S. Hosseinzadeh,et al.  The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats , 2016, Food & nutrition research.

[46]  C. Apovian.  Obesity: definition, comorbidities, causes, and burden. , 2016, The American journal of managed care.

[47]  K. Petersen,et al.  Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome , 2016, Nature.

[48]  J. Nicholson,et al.  Impact of the gut microbiota on inflammation, obesity, and metabolic disease , 2016, Genome Medicine.

[49]  T. Preston,et al.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.

[50]  J. O’Doherty,et al.  The Effect of Divergence in Feed Efficiency on the Intestinal Microbiota and the Intestinal Immune Response in Both Unchallenged and Lipopolysaccharide Challenged Ileal and Colonic Explants , 2016, PloS one.

[51]  J. Steele,et al.  The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent , 2015, PloS one.

[52]  G. Frühbeck,et al.  Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. , 2015, American journal of physiology. Endocrinology and metabolism.

[53]  G. Gibson,et al.  Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women. , 2015, The Journal of nutrition.

[54]  V. Dixit,et al.  Adipose tissue as an immunological organ , 2015, Obesity.

[55]  A. King,et al.  Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models. , 2014, The Journal of endocrinology.

[56]  Kouichi Miura,et al.  TOPIC HIGHLIGHT , 2014 .

[57]  W. Jia,et al.  Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s–PPARα axis signalling , 2014, Nature Communications.

[58]  Haiming Cao.  Adipocytokines in obesity and metabolic disease. , 2014, The Journal of endocrinology.

[59]  Kassem M. Makki,et al.  Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines , 2013, ISRN inflammation.

[60]  H. Sokol,et al.  Faecalibacterium prausnitzii and human intestinal health. , 2013, Current opinion in microbiology.

[61]  R. Flavell,et al.  NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy , 2013, Kidney international.

[62]  Jiyun Ahn,et al.  Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet , 2013, British Journal of Nutrition.

[63]  J. Nadler,et al.  Adipose Tissue-Specific Deletion of 12/15-Lipoxygenase Protects Mice from the Consequences of a High-Fat Diet , 2012, Mediators of inflammation.

[64]  H. Guillou,et al.  The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. , 2012, The Journal of clinical investigation.

[65]  K. Venema,et al.  Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects , 2012, European journal of clinical investigation.

[66]  Ian D. Caterson,et al.  Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice , 2012, PloS one.

[67]  R. Curi,et al.  Regulation of Inflammation by Short Chain Fatty Acids , 2011, Nutrients.

[68]  S. Deshpande,et al.  Clinical Study of Bacilluscoagulans Unique IS-2 (ATCC PTA-11748) in the Treatment of Patients with Bacterial Vaginosis , 2011, Indian Journal of Microbiology.

[69]  M. Fresno,et al.  Toll-like receptors, inflammation, metabolism and obesity , 2011, Archives of physiology and biochemistry.

[70]  Kiyomi Ito,et al.  Anti-Obesity and Anti-Diabetic Effects of Acacia Polyphenol in Obese Diabetic KKAy Mice Fed High-Fat Diet , 2011, Evidence-based complementary and alternative medicine : eCAM.

[71]  Sofianos Andrikopoulos,et al.  Evaluating the glucose tolerance test in mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[72]  P. Froguel,et al.  Inflammation is associated with a decrease of lipogenic factors in omental fat in women. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[73]  G. Ronnett,et al.  Fatty acid metabolism as a target for obesity treatment , 2005, Physiology & Behavior.

[74]  Bruce A. Johnson,et al.  Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator. , 2003, Molecular endocrinology.